Global Drug Discovery Services Market, Trends & Analysis - Forecasts To 2026

1. Global Drug Discovery Services Market, Trends & Analysis - Forecasts To 2026 By Process (Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation), By Type (Medicinal Chemistry Services, Biology Services, Drug Metabolism & Pharmacokinetics), By Drug Type (Small-Molecule Drugs, Biologic Drugs), By Therapeutic Area (Oncology, Neurology , Infectious and Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Other), By Company Type (Tier 1 Pharmaceutical Companies, Tier 2 Pharmaceutical Companies, Tier 3 Pharmaceutical Companies), By Region (North America, Europe, Asia Pacific and Rest of the World); Vendor Landscape, End User Landscape and Company Market Share Analysis & Competitor Analysis Drug Discovery Services Market: Insights The global drug discovery services market is estimated to witness a significant CAGR during the forecast period (2019-2026). The growth of the drug discovery services market is anticipated to increase with the growing demand from pharmaceutical sector, increasing R&D activities and emergence of new diseases across the globe among others. Request a free sample copy of the report @https://www.globalmarketestimates.com/report- summary.php?report_id=1650&report_name=global-drug-discovery- services-market Drug Discovery Services Market: By Process On the basis of process, the global drug discovery services market is segmented into target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation. The report contains quantitative insights about the following 1. 1.Introduction 1.Drug Discovery Services Market, By Process, 2018-2026 (USD Million) 2.Target Selection 1.Target Selection: Drug Discovery Services Market, 2018-2026 (USD Million) 3.Target Validation 1.Target Validation: Drug Discovery Services Market, 2018-2026 (USD Million) 4.Hit-To-Lead Identification

2. 1.Hit-To-Lead Identification: Drug Discovery Services Market, 2018- 2026 (USD Million) 5.Lead Optimization 1.Lead Optimization: Drug Discovery Services Market, 2018-2026 (USD Million) 6.Candidate Validation 1.Candidate Validation: Drug Discovery Services Market, 2018-2026 (USD Million) Drug Discovery Services Market: By Type On the basis of type, the global drug discovery services market is segmented into medicinal chemistry services, biology services, and drug metabolism & pharmacokinetics. The report contains quantitative insights about the following 1. 1.Introduction 1.Drug Discovery Services Market, By Type, 2018-2026 (USD Million) 2.Medicinal Chemistry Services 1.Medicinal Chemistry Services: Drug Discovery Services Market, 2018- 2026 (USD Million) 3.Biology Services 1.Biology Services: Drug Discovery Services Market, 2018-2026 (USD Million) 4.Drug Metabolism & Pharmacokinetics 1.Drug Metabolism & Pharmacokinetics: Drug Discovery Services Market, 2018-2026 (USD Million) Drug Discovery Services Market: By Drug Type On the basis of drug type, the global drug discovery services market is segmented into small-molecule drugs and biologic drugs. The report contains quantitative insights about the following 1. 1.Introduction 1.Drug Discovery Services Market, By Drug Type, 2018-2026 (USD Million) 2.Small-Molecule Drugs 1.Small-Molecule Drugs: Drug Discovery Services Market, 2018-2026 (USD Million) 3.Biologic Drugs 1.Biologic Drugs: Drug Discovery Services Market, 2018-2026 (USD Million) Drug Discovery Services Market: By Therapeutic Area

3. On the basis of therapeutic area, the global drug discovery services market is segmented into oncology, neurology, infectious and immune system diseases, digestive system diseases, cardiovascular diseases and among other. The report contains quantitative insights about the following 1. 1.Introduction 1.Drug Discovery Services Market, By Therapeutic Area, 2018-2026 (USD Million) 2.Oncology 1.Oncology: Drug Discovery Services Market, 2018-2026 (USD Million) 3.Neurology 1.Neurology: Drug Discovery Services Market, 2018-2026 (USD Million) 4.Infectious and Immune System Diseases 1.Infectious and Immune System Diseases: Drug Discovery Services Market, 2018-2026 (USD Million) 5.Digestive System Diseases 1.Digestive System Diseases: Drug Discovery Services Market, 2018- 2026 (USD Million) 6.Cardiovascular Diseases 1.Cardiovascular Diseases: Drug Discovery Services Market, 2018-2026 (USD Million) 7.Others 1.Others: Drug Discovery Services Market, 2018-2026 (USD Million) Drug Discovery Services Market: By Company Type On the basis of company type, the global drug discovery services market is segmented into tier 1 pharmaceutical companies, tier 2 pharmaceutical companies and tier 3 pharmaceutical companies. The report contains quantitative insights about the following: 1. 1.Introduction 1.Drug Discovery Services Market, By Company Type, 2018-2026 (USD Million) 2.Tier 1 Pharmaceutical Companies 1.Tier 1 Pharmaceutical Companies: Drug Discovery Services Market, 2018-2026 (USD Million) 3.Tier 2 Pharmaceutical Companies 1.Tier 2 Pharmaceutical Companies: Drug Discovery Services Market, 2018-2026 (USD Million) 4.Tier 3 Pharmaceutical Companies 1.Tier 3 Pharmaceutical Companies: Drug Discovery Services Market, 2018-2026 (USD Million) Drug Discovery Services Market: By Region

4. On the basis of region, the global Drug Discovery Services market is segmented into North America, Europe, Asia Pacific, Central & South America and Middle East & Africa. The countries covered include: U.S., Canada, Mexico, Germany, France, UK, Italy, Spain, China, India, Japan, South Korea, Australia, Brazil, Saudi Arabia, UAE, and South Africa among others. The report provides qualitative & quantitative insights both at a regional as well as country level. Drug Discovery Services Market: End Use Landscape The end-user landscape entails a list of current and prospective consumers prevailing across the regions. This section briefs you about company addresses, contact details, products, and regional presence of companies who are purchasing or are likely to purchase drug discovery services. The key end-users of the markets are Abbot, MacLeod, SunPharma and GSK among others. Drug Discovery Services Market: Vendor Landscape The report contains a chapter dedicated to vendors operating in the market, covering raw material manufactures, equipment developers, manufacturers, and distributors. The report provides these insights on a regional level. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence of companies. Drug Discovery Services Market: Share & Competitor Analysis Some of the key players operating in the drug discovery services market are America Holdings, Albany Molecular Research, Inc, Charles River Laboratories International, Inc, Evotec SE, Eurofins Scientific, WuXi AppTec, GenScript Biotech Corporation, Thermo Fisher Scientific, Inc., Pharmaceutical Product Development, LLC, Syngene International Ltd., and Selvita S.A. among others. Browse the report @https://www.globalmarketestimates.com/report- summary.php?report_id=1650&report_name=global-drug-discovery- services-market